Literature DB >> 32638021

Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.

Christian Bär1,2, Shambhabi Chatterjee1,2, Inês Falcão Pires3, Patrícia Rodrigues3, Joost P G Sluijter4, Reinier A Boon5,6,7, Rosa M Nevado8,9, Vicente Andrés8,9, Marida Sansonetti1,2,10,11, Leon de Windt10,11, Michele Ciccarelli12, Nazha Hamdani13,14, Stephane Heymans15,16, Raquel Figuinha Videira3,10,11, Carlo G Tocchetti17, Mauro Giacca18,19,20, Serena Zacchigna18,20, Stefan Engelhardt21,22, Stefanie Dimmeler23,24,25, Rosalinda Madonna26,27, Thomas Thum1,2.   

Abstract

Vast parts of mammalian genomes are actively transcribed, predominantly giving rise to non-coding RNA (ncRNA) transcripts including microRNAs, long ncRNAs, and circular RNAs among others. Contrary to previous opinions that most of these RNAs are non-functional molecules, they are now recognized as critical regulators of many physiological and pathological processes including those of the cardiovascular system. The discovery of functional ncRNAs has opened up new research avenues aiming at understanding ncRNA-related disease mechanisms as well as exploiting them as novel therapeutics in cardiovascular therapy. In this review, we give an update on the current progress in ncRNA research, particularly focusing on cardiovascular physiological and disease processes, which are under current investigation at the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. This includes a range of topics such as extracellular vesicle-mediated communication, neurohormonal regulation, inflammation, cardiac remodelling, cardio-oncology as well as cardiac development and regeneration, collectively highlighting the wide-spread involvement and importance of ncRNAs in the cardiovascular system. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Aging; Cardiovascular disease; MicroRNA; Non-coding RNA; Non-coding RNA therapy; Regeneration; Remodelling

Year:  2020        PMID: 32638021     DOI: 10.1093/cvr/cvaa195

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

1.  Investigating microRNAs in diabetic cardiomyopathy as tools for early detection and therapeutics.

Authors:  Priyanka Mathur; Vibha Rani
Journal:  Mol Cell Biochem       Date:  2022-07-02       Impact factor: 3.396

2.  MIAT, a potent CVD-promoting lncRNA.

Authors:  Chao Yang; Yong Zhang; Baofeng Yang
Journal:  Cell Mol Life Sci       Date:  2021-12-18       Impact factor: 9.261

Review 3.  Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress.

Authors:  Jean C Bikomeye; Janée D Terwoord; Janine H Santos; Andreas M Beyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-05       Impact factor: 5.125

4.  CircERBB2IP promotes post-infarction revascularization via the miR-145a-5p/Smad5 axis.

Authors:  Xianping Long; Zhimei Qiu; Chaofu Li; Yan Wang; Jiao Li; Ranzun Zhao; Jidong Rong; Ning Gu; Jinson Yuan; Junbo Ge; Bei Shi
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-20       Impact factor: 10.183

5.  Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.

Authors:  Kasper Thystrup Karstensen; Aleks Schein; Andreas Petri; Martin Bøgsted; Karen Dybkær; Shizuka Uchida; Sakari Kauppinen
Journal:  Noncoding RNA       Date:  2020-12-28

6.  miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations.

Authors:  Pasquale Mone; Jessica Gambardella; Xujun Wang; Stanislovas S Jankauskas; Alessandro Matarese; Gaetano Santulli
Journal:  Res Sq       Date:  2021-02-02

Review 7.  MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review.

Authors:  Liuying Chen; Yizhou Xu
Journal:  Front Cardiovasc Med       Date:  2021-11-24

Review 8.  Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia-Reperfusion Injury.

Authors:  Mihnea-Cosmin Marinescu; Andrada-Luciana Lazar; Monica Mihaela Marta; Angela Cozma; Cristina-Sorina Catana
Journal:  Int J Mol Sci       Date:  2022-03-01       Impact factor: 5.923

Review 9.  The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases.

Authors:  Denise Busscher; Reinier A Boon; Rio P Juni
Journal:  Clin Sci (Lond)       Date:  2022-08-12       Impact factor: 6.876

Review 10.  The vasculature: a therapeutic target in heart failure?

Authors:  Guillermo Luxán; Stefanie Dimmeler
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.